We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nasal Balloons Treat Otitis Media in Children

By HospiMedica International staff writers
Posted on 12 Aug 2015
A new study suggests that autoinflation of nasal balloons in young children with otitis media with effusion (OME) is effective in clearing effusions and improving symptoms.

Researchers at the University of Southampton (United Kingdom) conducted an open, pragmatic randomized controlled trial set in 43 family practices in the United Kingdom. More...
Children aged 4–11 years with a recent history of ear symptoms and OME in one or both ears, as confirmed by tympanometry, were allocated to receive either nasal balloon autoinflation three times daily for 1–3 months plus usual care, or usual care alone. Clearance of middle ear fluid at one and three months was assessed by experts masked to allocation.

The results showed that of the 320 children enrolled in the study, those receiving autoinflation were more likely than controls to have normal tympanograms at one and three months. Compliance was high, 89% at one month and 80% at three months. The researchers found that nasal balloon autoinflation also produced greater improvements in ear-related quality of life, with adverse events mild, infrequent, and comparable between groups. The study was published on July 27, 2015, in the Canadian Medical Association Journal (CMAJ).

“So many children get glue ear who don't get any treatment. They're not really bad enough to warrant an operation, but it's bad enough to affect their hearing and warrant some medical intervention,” said lead author Ian Williamson, MD. “That pressure that you generate in the nose is sufficient to open up the tube that isn’t really opening properly. It forces air into the middle ear; then the fluid can drain out of it.”

OME is characterized by a nonpurulent effusion of the middle ear that may be mucoid or serous. Symptoms usually involve hearing loss or aural fullness, but typically do not involve pain or fever. In children, hearing loss is generally mild and is often detected only with an audiogram. In general, inpatient care for OME is not required unless complications that threaten the stability of the patient's condition are suspected. A number of medical interventions have been suggested for the treatment of OME, including surgical intervention with pressure equalization tubes (PETs) and adenoidectomy.

Related Links:

University of Southampton



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.